ArticleNucleic acids research2026
Mechanism of negative supercoil relaxation by Topoisomerase IV.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Type II topoisomerases are essential enzymes that alter DNA topology by making a transient double-stranded break in one segment of the DNA and passing another DNA segment through the break such that the sign of the crossing DNA segments is inverted. DNA gyrase has served as a paradigm for mechanistic studies of topoisomerase action. Prescient biochemistry predicting a positive sign for the crossing DNA segments during DNA gyrase supercoiling activity has recently been confirmed by cryo-electron microscope studies of the enzyme bound to DNA. These studies demonstrated a central role of the C-terminal domain of the GyrA subunit in shaping the DNA crossover. We show biochemically that exchanging the DNA GyrA CTD for the homologous one from the ParC subunit of Topoisomerase IV alters the orientation of the DNA crossover from a positive one to a negative one. The sign of the pre-catalytic DNA crossover in Topoisomerase IV is also negative. We suggest that relaxation of negatively supercoiled DNA by Topoisomerase IV proceeds by the opposite of the mechanism by which DNA gyrase supercoils DNA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.